Tag: TEER
TriClip TEER system for TR repair given US FDA approval
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's TriCl...
AI-derived risk score may improve planning of TEER for secondary mitral regurgitation
A novel risk score derived from artificial intelligence (AI) may be more effective than currentl...
ACC 2023: Quality of life improvements drive benefit for transcatheter therapy in TRILUMINATE pivotal trial
Hotly-anticipated results of the randomised TRILUMINATE pivotal trial, presented during the 2023...
One-year real-world data “promising” for transcatheter tricuspid repair
One-year insights from the bRIGHT registry, detailing real-world results of tricuspid transcath...
TCT 2022: TEER in cardiogenic shock patients shows promise for lowering mortality and heart failure hospitalisation
Analysis of data from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) ...
Edwards’ Pascal Precision transcatheter valve repair system receives FDA approval for degenerative mitral regurgitation
Edwards Lifesciences has announced that its Pascal Precision transcatheter valve repair system for t...
“Encouraging” early results for TEER seen in bRIGHT registry
The first analysis of findings from the bRIGHT registry, detailing real-world results of t...
